GTC Biotherapeutics, a developer of recombinant blood proteins, has announced that the FDA has assigned priority review to the companys biologic license application for ATryn.
Inverness Medical Physician Diagnostics Group, a division of Inverness Medical Innovations, announced the launch of the INRatio®2 PT/INR Monitoring System, a portable device that measures blood-clotting time, also known as prothrombin time, using one drop of blood from a patient's finger.
EKOS Corporation announced the launch of the EkoSonic™ Endovascular System (EkoSonic ES) with Rapid Pulse Modulation (RPM) for the dissolution of vascular blood clots. EkoSonic ES is the only endovascular system that can deliver microsonic energy and thrombolytic drugs simultaneously, providing a safer, faster and more complete way to remove clots by accelerating dissolution.
is urging New Zealanders to make submissions to the Environmental Risk Management Authority (ERMA) regarding its applications currently before the authority.
Inverness Medical Physician Diagnostics Group, a division of Inverness Medical Innovations, today announced the launch of the INRatio(R)2 PT/INR Monitoring System, a portable device that measures blood-clotting time, also known as prothrombin time, using one drop of blood from a patient's finger. The INRatio2 is used by healthcare professionals and their patients in the management of warfarin, a ...
